Prospective Clinical Assessment Study in Children With Hypochondroplasia
NCT06410976 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-10-10
Summary
This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).
Conditions
Sponsors & Collaborators
-
QED Therapeutics, Inc., a Bridgebio company
lead INDUSTRY
Eligibility
- Min Age
- 30 Months
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-05
- Primary Completion
- 2026-10-31
- Completion
- 2026-10-31
Countries
- United States
- Australia
- Canada
- France
- Norway
- Portugal
- Singapore
- Spain
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
NCT01603095 ·Status: COMPLETED
-
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
NCT07073014 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)
NCT02724228 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia
NCT06164951 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 ·Status: RECRUITING
-
Extension Study of Infigratinib in Children With Achondroplasia (ACH)
NCT05145010 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
NCT06433557 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Molecular Basis of the Growth Axis in Short Stature
NCT00453245 ·Status: COMPLETED
-
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
NCT06455059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
NCT05328050 ·Status: RECRUITING
-
Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.
NCT07333521 ·Status: RECRUITING
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
NCT01243892 ·Status: TERMINATED
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Growth Retardation In Children With Special Pathological Conditions Or Disease
NCT00163215 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
NCT07126262 ·Status: RECRUITING ·Phase: PHASE2
-
Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone
NCT01626833 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
NCT03288103 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
NCT02616562 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia
NCT04638153 ·Status: TERMINATED ·Phase: PHASE2
-
Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
NCT00097526 ·Status: COMPLETED
-
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
NCT01435629 ·Status: COMPLETED
-
Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia
NCT05116046 ·Status: TERMINATED ·Phase: PHASE2